Decreased seizure threshold in an eclampsia-like model induced in pregnant rats with lipopolysaccharide and pentylenetetrazol treatments

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Huang, Qian ^a   Liu, Lei ^a   Hu, Bihui ^a   Di, Xiaodan ^a,b   Brennecke, Shaun Patrick ^c   Liu, Huishu ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MAGNESIUM SULFATE; PENTETRAZOLE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 1; ANTICONVULSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; ECLAMPSIA; EPILEPTOGENESIS; FEMALE; GESTATIONAL AGE; HYPERTENSION; INFLAMMATION; LATENT PERIOD; LIVER DYSFUNCTION; NONHUMAN; PREGNANCY; PROTEIN BLOOD LEVEL; RAT; SEIZURE; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD; URINARY EXCRETION; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; HUMAN; PATHOLOGY; PREGNANCY OUTCOME; SEIZURES; SPRAGUE DAWLEY RAT; TIME; TOXICITY;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; ECLAMPSIA; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MAGNESIUM SULFATE; PENTYLENETETRAZOLE; PREGNANCY; PREGNANCY OUTCOME; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; TIME FACTORS;

EID: 84895892788     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089333     Document Type: Article

References (43)

1. Douglas KA, Redman CW (1994) Eclampsia in the United Kingdom. BMJ. 309: 1395-400. (Pubitemid 24351401)
2. Abalos E, Cuesta C, Grosso AL, Chou D, Say L (2013) Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 170: 1-7.
3. Ghulmiyyah L, Sibai B (2012) Maternal mortality from preeclampsia/ eclampsia. Semin Perinatol 36: 56-59.
4. Bell MJ (2010) A historical overview of preeclampsia-eclampsia. J Obstet Gynecol Neonatal Nurs 39: 510-518.
5. Faas MM, Schuiling GA, Baller JF, Visscher CA, Bakker WW (1994) A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 171: 158-164. (Pubitemid 24254435)
6. Sunderland N, Hennessy A, Makris A (2011) Animal models of pre-eclampsia. Am J Reprod Immunol 65: 533-541.
7. McCarthy FP, Kingdom JC, Kenny LC, Walsh SK (2011) Animal models of preeclampsia; uses and limitations. Placenta 32: 413-419.
8. Yallampalli C, Garfield RE (1993) Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 169: 1316-1320. (Pubitemid 24001657)
9. Melgert BN, Spaans F, Borghuis T, Klok PA, Groen B, et al. (2012) Pregnancy and preeclampsia affect monocyte subsets in humans and rats. PLoS One 7(9): e45229.
10. Rusterholz C, Hahn S, Holzgreve W (2007) Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol 29: 151-162. (Pubitemid 47596394)
11. Redman CW, Sargent IL (2003) Pre-eclampsia, the placenta and the maternal systemic inflammatory response-a review. Placenta. 24 Suppl A: S21-27.
12. Racine RJ (1972) Modification of seizure activity by electrical stimulation. I. After-discharge threshold. Electroencephalogr Clin Neurophysiol 32: 269-279.
13. Racine RJ (1975) Modification of seizure activity by electrical stimulation: cortical areas. Electroencephalogr Clin Neurophysiol 38: 1-12.
14. Cotton DB, Hallak M, Janusz C, Irtenkauf SM, Berman RF (1993) Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizures. Am J Obstet Gynecol 168: 974-978. (Pubitemid 23096030)
15. Cotton DB, Janusz CA, Berman RF (1992) Anticonvulsant effects of magnesium sulfate on hippocampal seizures: therapeutic implications in preeclampsia-eclampsia. Am J Obstet Gynecol 166: 1127-1134; discussion 1134-1136.
16. Spencer SS, Nguyen DK, Duckrow RB (2009) Invasive EEG in Presurgical Evaluation of Epilepsy, Chapter 53 of the Treatment of Epilepsy, 3rd ed. Hoboken, NJ: Wiley. pp. 767-798.
17. Konishi Y, Matsu-ura T, Mikoshiba K, Tamura T (2001) Stimulation of gene expression of NeuroD-related factor in the mouse brain following pentylenetetrazol-induced seizures. Brain Res Mol Brain Res 97: 129-136. (Pubitemid 34025092)
18. Zienowicz M, Wisłowska A, Lehner M, Taracha E, Skórzewska A, et al. (2005) The effect of fluoxetine in a model of chemically induced seizures-behavioral and immunocytochemical study. Neurosci Lett 373: 226-331.
19. Rocha L, Briones M, Ackermann RF, Anton B, Maidment NT, et al. (1996) Pentylenetetrazol-induced kindling: early involvement of excitatory and inhibitory systems. Epilepsy Res 26: 105-113. (Pubitemid 26420734)
20. Craig CR, Colasanti BK (1988) A study of pentylenetetrazol kindling in rats and mice. Pharmacol Biochem Behav 31: 867-1870.
21. You Y, Bai H, Wang C, Chen LW, Liu B, et al. (2011) Myelin damage of hippocampus and cerebral cortex in rat pentylenetetrazol model. Brain Res 1381: 208-216.
22. Sibai BM (1990) Magnesium sulphate is the ideal anticonvulsant in preeclampsia-eclampsia. Am J Obstet Gynecol 162: 1141-1145.
23. Eclampsia Trial Collaborative Group (1995) Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet 345: 1455-1463.
24. Altman D, Carroli G, Duley L, Farrell B, Moodley J, et al. (2002) Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised, placebo-controlled trial. Lancet 359: 1877-1890. (Pubitemid 34615765)
25. Paller MS (1998) Hypertension in pregnancy. J Am Soc Nephrol 9: 314-321.
26. Lu J, Pfister M, Ferrari P, Chen G, Sheiner L (2002) Pharmacokinetic- pharmacodynamic modelling of magnesium plasma concentration and blood pressure in preeclamptic women. Clin Pharmacokinet 41: 1105-1113. (Pubitemid 35246784)
27. Pandhi P, Saha L, Malhotra S (2002) Effect of oral magnesium supplementation on experimental pre-eclampsia induced by prolonged blockade of nitric oxide synthesis in pregnant rats. Indian J Exp Biol 40: 349-351. (Pubitemid 34212857)
28. Standley CA, Batia L, Yueh G (2006) Magnesium sulfate effectively reduces blood pressure in an animal model of preeclampsia. J Matern Fetal Neonatal Med 19: 171-176.
29. Seki H, Matuoka K, Inooku H, Takeda S (2007) TNF-alpha from monocyte of patients with pre-eclampsia-induced apoptosis in human trophoblast cell line. J Obstet Gynaecol Res 33: 408-416. (Pubitemid 47222721)
30. Alanbay I, Coksuer H, Ercan CM, Ustun Y, Pala G, et al. (2012) Chitotriosidase, interleukin-1 beta and tumor necrosis factor alpha levels in mild preeclampsia. Arch Gynecol Obstet 285: 1505-1511.
31. Tosun M, Celik H, Avci B, Yavuz E, Alper T, et al. (2010) Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumornecrosis factor-alpha in normal pregnancies and in pregnanciescomplicated by preeclampsia. J Matern Fetal Neonatal Med 23: 880-886.
32. Szarka A, Rigó J, Lázár L, Beko G, Molvarec A (2010) Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol 11: 59.
33. Kalinderis M, Papanikolaou A, Kalinderi K, Ioannidou E, Giannoulis C, et al. (2011) Elevated serum levels of interleukin-6, interleukin-1β and human chorionic gonadotropin in pre-eclampsia. Am J Reprod Immunol 66: 468-475.
34. Holcberg G, Amash A, Sapir O, Sheiner E, Levy S, et al. (2008) Perfusion with lipopolysaccharide differently affects the secretion of interleukin-1 beta and interleukin-1 receptor antagonist by term and preterm human placentae. Placenta 29: 593-601.
35. Amash A, Holcberg G, Sapir O, Huleihel M (2012) Placental secretion of interleukin-1 and interleukin-1 receptor antagonist inpreeclampsia: effect of magnesium sulfate. J Interferon Cytokine Res 32: 432-441.
36. Cipolla MJ, Pusic AD, Grinberg YY, Chapman AC, Poynter ME, et al. (2012) Pregnant serum induces neuroinflammation and seizure activity via TNFα. Exp Neurol. 234(2): 398-404.
37. Dowling O, Chatterjee PK, Gupta M, Tam Tam HB, Xue X, et al. (2012) Magnesium sulfate reduces bacterial LPS-induced inflammation at the maternal-fetal interface. Placenta 33: 392-398.
38. Tam Tam HB, Dowling O, Xue X, Lewis D, Rochelson B, et al. (2011) Magnesium sulfate ameliorates maternal and fetal inflammation in a rat model of maternal infection. Am J Obstet Gynecol 204: 364.e1-8.
39. De Vivo A, Baviera G, Giordano D, Todarello G, Corrado F, et al. (2008) Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. Acta Obstet Gynecol Scand 87: 837-842.
40. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, et al. (2012) The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disordersand its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 206: 58.e1-8.
41. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350: 672-683. (Pubitemid 38364626)
42. Romero R, Nien JK, Espinoza J, Todem D, Fu W, et al. (2008) A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 21: 9-23.
43. Xu Y, Zhang Y, Guo Z, Yin H, Zeng K, et al. (2012) Increased placental growth factor in cerebrospinal fluid of patients withepilepsy. Neurochem Res 37: 665-670.